Effect of Thyroid Disorders in Liver Diseases
NCT06071923 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2023-10-10
Summary
Aims of the Research
1. To detect correlation between hyperthyroidism and non alcoholic fatty liver disease (NAFLD).
2. To detect hepatic risk in subclinical and clinical hypothyroidism .
3. To detect early liver disorders in thyroid disorders using fibroscan .
Conditions
- Fatty Liver Disease
Interventions
- DEVICE
-
Fibroscan
Scan the liver for metabolic fatty changes
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2025-01-01
- Completion
- 2025-02-28
More Related Trials
-
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
NCT04553796 ·Status: UNKNOWN
-
Association of Non-alcoholic Fatty Liver Disease and Coronary Artery Disease
NCT01638832 ·Status: UNKNOWN ·Phase: NA
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus
NCT06715189 ·Status: NOT_YET_RECRUITING
-
Relation Between NAFLD and BM DENSITY
NCT06038253 ·Status: NOT_YET_RECRUITING
-
Biomarkers in the Diagnosis and Prognosis of NAFLD
NCT06098417 ·Status: RECRUITING
-
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut University Hospitals
NCT04482153 ·Status: UNKNOWN
-
Prevalence of NAFLD in T1DM Patients
NCT06445361 ·Status: RECRUITING ·Phase: NA
-
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
NCT01997424 ·Status: COMPLETED ·Phase: NA
-
Identification of Liver Fibrosis Biomarkers
NCT06819917 ·Status: RECRUITING
-
Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
NCT07168551 ·Status: NOT_YET_RECRUITING
-
NASH and Coronary Disease
NCT03819283 ·Status: UNKNOWN ·Phase: NA
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study
NCT01306110 ·Status: COMPLETED
-
A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations
NCT03726827 ·Status: COMPLETED
-
Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease
NCT02779946 ·Status: COMPLETED
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
FibroScan-Reproducibility and Repeatability Study
NCT06877026 ·Status: COMPLETED ·Phase: NA
-
Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
NCT06119997 ·Status: RECRUITING
-
Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBV
NCT06589167 ·Status: NOT_YET_RECRUITING
-
Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among NAFLD Patients
NCT03250572 ·Status: COMPLETED
-
Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis
NCT03842748 ·Status: UNKNOWN
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
NCT07222813 ·Status: NOT_YET_RECRUITING ·Phase: NA